Indications for intra-venous immunoglobulin treatment in rheumatic diseases
Con l'immissione in commercio delle Immunoglobuline per uso endovenoso (IVIG), che risale ormai al 1981, è stato possibile ampliarne enormemente le utilizzazioni terapeutiche, dimostrando l'efficacia di tale trattamento in condizioni cliniche le più diverse. In particolare, sulla base de...
Saved in:
Main Authors: | F. Laghi Pasini (Author), P.L. Capecchi (Author), F. Bellisai (Author), P.E. Lazzerini (Author), M. Galeazzi (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2003-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
by: Lazzerini PE, et al.
Published: (2016) -
Churg-Strauss Syndrome and pregnancy Successful treatment with intravenous immunoglobulin - Reply
by: M. Galeazzi
Published: (2003) -
MicroRNAs in autoimmune rheumatic diseases
by: G.D. Sebastiani, et al.
Published: (2012) -
Combined interferon a2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial - Reply
by: M. Galeazzi, et al.
Published: (2011) -
Osteoporosis and rheumatic diseases
by: N. Maruotti, et al.
Published: (2014)